Sort
15,842 grants matching “pancreatic cancer”
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$849,274Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Cdk5-mediated phosphorylation and neuronal functions
$849,004Ashok B. Kulkarni · Dental & Craniofacial Research · Z01 · FY2007 · DE
Role of Neurotrophins in the Development of the Mammalian Nervous System
$848,710Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
CSHL-JAX Patient-Derived Models of Pancreatic Cancer as Systems for Investigating Tumor Heterogeneity
$848,343David Tuveson · Cold Spring Harbor Laboratory · U01 · FY2020 · CA
Development of a companion diagnostic to identify patients who respond to microbiome-targeting drugs
$846,715Bret David Wallace · Symberix, Inc. · R44 · FY2021 · GM
ENHANCING EARLY DETECTION OF PANCREATIC CANCER USING GPT-EMBEDDED EHR MODELS: A NOVEL APPROACH FOR IMPROVED PREDICTIVE PERFORMANCE AND INTERPRETABILITY
$845,928The Trustees Of Columbia University In The City Of New York · · FY2025 · Defense Health Agency
CSHL-JAX Patient-Derived Models of Pancreatic Cancer as Systems for Investigating Tumor Heterogeneity
$844,970David Tuveson · Cold Spring Harbor Laboratory · U01 · FY2021 · CA
METEOR-BioLogical Specimen Translation (METEOR-BLST)
$844,906Michael Benjamin Major · Washington University · U54 · FY2025 · CA
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis
$844,766Matthew J. Flick · Univ Of North Carolina Chapel Hill · U01 · FY2021 · HL
Fibroblast orchestration of the immune response in pancreatic cancer
$844,294Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · U01 · FY2022 · CA
Cancer Gene Discovery to Identify Targetable Targets
$843,904Carlo M Croce · Ohio State University · R35 · FY2021 · CA
Study Of Factors That Induce Differentiation Of Pancreatic Precursor Cells
$843,603Marvin Gershengorn · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Biological Functions of Chromosomal Proteins
$842,732Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Translational Development of a Targeted and Stroma-penetrating Nanoparticle Drug for Pancreatic Cancer Therapy
$841,919Lei Zhu · Migra-Therapeutics, Llc · R44 · FY2023 · CA
Center for Applied Preclinical Research (CAPR)
$841,462Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Modulation of Therapeutic Response
$839,713James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
$838,914William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Biological Functions of Chromosomal Proteins
$837,688Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy
$836,804Amanda M Schalk · Enzyme By Design, Inc. · R44 · FY2022 · CA
Identification of human tumor-associated antigens
$835,772Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Prevention & Metastasis: Final Frontiers in Colon Cancer
$835,111Robert J Coffey · Vanderbilt University · U01 · FY2006 · CA
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis
$834,158Matthew J. Flick · Univ Of North Carolina Chapel Hill · U01 · FY2022 · HL
Role of Neurotrophins in the Development of the Mammalian Nervous System
$834,125Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Prevention &Metastasis: Final Frontiers in Colon Cancer
$833,263Vanderbilt University · U01 · FY2005 · CA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
$832,842Laura D Attardi · Stanford University · R35 · FY2015 · CA